These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transvenous pacing causing tamponade in patients receiving glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention. Jeilan M; Richardson G; Gershlick A J Invasive Cardiol; 2007 Feb; 19(2):E40-2. PubMed ID: 17268050 [No Abstract] [Full Text] [Related]
5. Duration of action of GpIIb-IIIa antagonists. Johnson K Crit Care Nurse; 2000 Oct; 20(5):16. PubMed ID: 11878484 [No Abstract] [Full Text] [Related]
7. Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists. Steinhubl SR Coron Artery Dis; 2003 Aug; 14(5):381-6. PubMed ID: 12878903 [No Abstract] [Full Text] [Related]
8. [Pathophysiology, clinical and experimental possibilities of pericardial tamponade]. Bari G; Érces D; Varga G; Szűcs S; Bogáts G Orv Hetil; 2018 Feb; 159(5):163-167. PubMed ID: 29376423 [TBL] [Abstract][Full Text] [Related]
9. [The use of BP IIb/IIIa inhibitors]. Polimeno S; De Rosa V Ital Heart J Suppl; 2000 Jul; 1(7):958-61. PubMed ID: 10935749 [No Abstract] [Full Text] [Related]
16. [Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization]. Albuquerque A Rev Port Cardiol; 2001 Sep; 20(9):927-8. PubMed ID: 11763604 [No Abstract] [Full Text] [Related]
17. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions. Gambhir DS; Mukhopadhyay S Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774 [No Abstract] [Full Text] [Related]
18. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients. Keularts IM; Béguin S; de Zwaan C; Hemker HC Thromb Haemost; 1998 Sep; 80(3):370-1. PubMed ID: 9759611 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. Galli M; Vassanelli C Ital Heart J Suppl; 2001 Oct; 2(10):1127-9. PubMed ID: 11723619 [No Abstract] [Full Text] [Related]
20. [Comparison of 2 platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization]. Rossi ML; Merlini PA Ital Heart J Suppl; 2001 Oct; 2(10):1130-2. PubMed ID: 11723620 [No Abstract] [Full Text] [Related] [Next] [New Search]